Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia

Growth Hormone and IGF Research

Volumn 16, Issue 4, 2006, Pages 211-216

  Fukuda, Izumi ^a   Hizuka, Naomi ^a   Ishikawa, Yukiko ^a   Yasumoto, Kumiko ^a   Murakami, Yuko ^a   Sata, Akira ^a   Morita, Junko ^a   Kurimoto, Makiko ^a   Okubo, Yumiko ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypoglycemia; Insulin like growth factor II; Tumor

Indexed keywords

GLUCOSE; IMMUNOREACTIVE INSULIN; POTASSIUM; PROTEIN; SOMATOMEDIN B; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOGLYCEMIA; HYPOINSULINEMIA; HYPOKALEMIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL RECORD; MOLECULAR WEIGHT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECURRENT DISEASE; STOMACH CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, RENAL CELL; CHILD; FEMALE; FIBROSARCOMA; GASTROINTESTINAL STROMAL TUMORS; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; LEIOMYOSARCOMA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PANCREATIC NEOPLASMS; PHEOCHROMOCYTOMA; PROSTATIC NEOPLASMS; PROTEINS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 33748092018     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.05.003     Document Type: Article

References (23)

1. Phillips L.S., and Robertson D.G. Insulin-like growth factors and non-islet cell tumor hypoglycemia. Metabolism 42 (1993) 1093-1101
2. Daughaday W.H., Emanuele M.A., Brooks M.H., Barbato A.L., Kapadia M., and Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. The New England Journal of Medicine 319 (1988) 1434-1440
3. Hizuka N., Asakawa-Yasumoto K., Takano K., et al. Hypoglycemic effect of insulin-like growth factor II (IGF-II) is mediated mainly though insulin and/or IGF-I receptor but not IGF-II receptor. Clinical Pediatric Endoclinology 5 Suppl. (1996) 77-83
4. Lowe Jr. W.L., Roberts Jr. C.T., LeRoith D., et al. Insulin-like growth factor-II in non-islet cell tumors associated with hypoglycemia: Increased levels of messenger ribonucleic acid. The Journal of Clinical Endocrinology and Metabolism 69 (1989) 1153-1159
5. Shapiro E.T., Bell G.I., Polonsky K.S., Rubenstein A.H., and Kew M.C. Tager HS tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. The Journal of Clinical Investigation 85 (1990) 1672-1679
6. Daughaday W.H. Hypoglycemia in patients with non-islet cell tumors. Endocrinology and Metabolism Clinics of North America 18 (1989) 91-101
7. Takayama-Hasumi S., Eguchi Y., Satoh A., Morita, and Hirata Y. Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan. Diabetes Research and Clinical Practice 10 (1990) 211-214
8. Baxter R.C. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. Hormone Research 46 (1996) 195-201
9. Hizuka N., Fukuda I., Takano K., Okubo Y., Asakawa-Yasumoto K., and Demura H. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia. Endocrine Journal 45 Suppl. (1998) S61-S65
10. Hizuka N., Fukuda I., Takano K., Asakawa-Yasumoto K., Okubo Y., and Demura H. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 2875-2877
11. Liu F., Barker B.K., Powell D.R., and Hints R.L. Characterization of proinsulin-like growth factor-II E-resion immunoreactivity in serum and other biological fluids. The Journal of Clinical Endocrinology and Metabolism 76 (1993) 1095-1100
12. Zapf J., Futo E., Peter M., and Froesch E.R. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?. The Journal of Clinical Investigation 90 (1992) 2574-2584
13. Baxter R.C., and Daughaday W.H. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to non-islet cell tumors. The Journal of Clinical Endocrinology and Metabolism 73 (1991) 696-702
14. Fukuda I., Hizuka N., Takano K., et al. Circulating forms of insulin-like growth factor II (IGF-II) in patients with non-islet cell tumor hypoglycemia. Endocrinology and Metabolism 1 (1994) 89-95
15. Frystyk J., Skjaerbaek C., Zapf J., and Orskov H. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 41 (1998) 589-594
16. Ron D., Powers A.C., Pandian M.R., Godine J.E., and Axelrod L. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia. The Journal of Clinical Endocrinology and Metabolism 68 (1989) 701-706
17. Axelrod L., and Ron D. Insulin-like growth factor II and the riddle of tumour-induced hypoglycaemia. New England Journal of Medicine 319 (1988) 1477-1479
18. Miyakawa M., Hizuka N., Takano K., et al. Radioimmunoassay for insulin-like growth factor I (IGF-I) using biosynthetic IGF-I. Endocrinologia Japonica 33 (1986) 795-801
19. Asakawa K., Hizuka N., Takano K., et al. Radioimmunoassay for insulin-like growth factor II (IGF-II). Endocrinologia Japonica 37 (1990) 607-614
20. N. Hizuka, I. Fukuda, Y. Ishikawa, K. Takano, Insulin-like growth factor II (IGF-II) and non-islet cell tumor hypoglycemia (NICTH), in: D. Le Roith, W. Zumkeller, R. Baxter, (Eds.), Insulin-like Growth Factors, http://Eurekah.Com, 2003, pp. 434-440.
21. Service F.J. Hypoglycemic disorders. The New England Journal of Medicine 332 (1995) 1144-1152
22. Daughaday W.H., and Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. The Proceedings of the National Academy of Science (USA) 86 (1989) 6778-6782
23. Daughaday W.H., Trivedi B., and Baxter R.C. Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II. Endocrine 3 (1995) 425-428